RIKADA study reveals risk factors in pediatric primary cardiomyopathy
Journal of the American Heart Association Jul 29, 2019
Al-Wakeel-Marquard N, et al. - Researchers investigated clinical risk factors in pediatric primary cardiomyopathy in this prospective study- the RIKADA (Risk Stratification in Children and Adolescents with Primary Cardiomyopathy) study. They carried out in-depth phenotypic and genetic characterization of 60 index pediatric patients with primary cardiomyopathy (median age: 7.8 years) and their first-degree family members (n=124). The factors that showed association with adverse outcome and therefore are recommended to be considered for risk assessment in pediatric primary cardiomyopathies were: lower body surface area, increased N-terminal pro–brain natriuretic peptide, left ventricular dysfunction or dilatation, late gadolinium enhancement, and increased number of variants of interest.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries